NPI 1851062715 — Billing Profile & Reimbursement Data

This provider’s Medicare business is concentrated and measurable: total Medicare revenue is $7.2M while there is no Medicaid billing on file, making the organization effectively single‑payer (Medicare) in scale for the recorded period. The absence of any Medicaid claims ("none below") suggests limited or no participation in state Medicaid programs and little exposure to Medicaid-managed care volumes.

Revenue concentration is extreme: the precomputed top three Medicare codes account for 77.5% of this provider’s total Medicare revenue, and a single code, K1034, alone represents $4.8M (72.2% of Medicare revenue). That level of concentration indicates material dependence on reimbursement and billing policy for K1034 to sustain current Medicare revenue levels.

K1034 is an outlier nationally and dominates this profile: the code K1034 (provision of nonprescription self‑administered COVID-19 tests) shows $4.8M in revenue and 401.2K claims and ranks #95 of 30143 providers nationally (100th percentile; extreme outlier). This pattern is consistent with very large-scale distribution or billing for OTC COVID‑19 tests to Medicare beneficiaries compared with typical national volumes.